Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Synergistic effect of human uterine cervical mesenchymal stem cell secretome and paclitaxel on triple negative breast cancer

Fig. 1

(A) Relative proliferative capacity of MDA-MB-231 cells treated for 48 h with CM-hUCESC, paclitaxel (1 µM, 3 µM and 5 µM) and the combination of paclitaxel (1 µM, 3 µM and 5 µM) + CM-hUCESC. (B) Relative proliferative capacity of primary tumor cells from TNBC treated for 48 h with CM-hUCESC, paclitaxel (1 µM, 3 µM and 5 µM) and the combination of paclitaxel (1 µM, 3 µM and 5 µM) + CM-hUCESC. *p < 0.05, ***p < 0.0001

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512